Van Bambeke F - Search Results

1

Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux.

Van Bambeke F, Pagès JM, Lee VJ. Van Bambeke F, et al. Recent Pat Antiinfect Drug Discov. 2006 Jun;1(2):157-75. doi: 10.2174/157489106777452692. Recent Pat Antiinfect Drug Discov. 2006. PMID: 18221142 Review.

2

Antibiotic efflux pumps.

Van Bambeke F, Balzi E, Tulkens PM. Van Bambeke F, et al. Biochem Pharmacol. 2000 Aug 15;60(4):457-70. doi: 10.1016/s0006-2952(00)00291-4. Biochem Pharmacol. 2000. PMID: 10874120 Review.

3

Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics.

Van Bambeke F, Michot JM, Tulkens PM. Van Bambeke F, et al. J Antimicrob Chemother. 2003 May;51(5):1067-77. doi: 10.1093/jac/dkg225. Epub 2003 Apr 14. J Antimicrob Chemother. 2003. PMID: 12697641 Review. No abstract available.

4

Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy.

Van Bambeke F, Glupczynski Y, Plésiat P, Pechère JC, Tulkens PM. Van Bambeke F, et al. J Antimicrob Chemother. 2003 May;51(5):1055-65. doi: 10.1093/jac/dkg224. Epub 2003 Apr 14. J Antimicrob Chemother. 2003. PMID: 12697642 Review. No abstract available.

5

Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.

Seral C, Carryn S, Tulkens PM, Van Bambeke F. Seral C, et al. Among authors: van bambeke f. J Antimicrob Chemother. 2003 May;51(5):1167-73. doi: 10.1093/jac/dkg223. Epub 2003 Apr 14. J Antimicrob Chemother. 2003. PMID: 12697643

6

Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives.

Van Bambeke F, Barcia-Macay M, Lemaire S, Tulkens PM. Van Bambeke F, et al. Curr Opin Drug Discov Devel. 2006 Mar;9(2):218-30. Curr Opin Drug Discov Devel. 2006. PMID: 16566292 Review.

7

Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.

Mesaros N, Nordmann P, Plésiat P, Roussel-Delvallez M, Van Eldere J, Glupczynski Y, Van Laethem Y, Jacobs F, Lebecque P, Malfroot A, Tulkens PM, Van Bambeke F. Mesaros N, et al. Among authors: van laethem y, van eldere j, van bambeke f. Clin Microbiol Infect. 2007 Jun;13(6):560-78. doi: 10.1111/j.1469-0691.2007.01681.x. Epub 2007 Jan 31. Clin Microbiol Infect. 2007. PMID: 17266725 Free article. Review.

8

A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa.

Mesaros N, Glupczynski Y, Avrain L, Caceres NE, Tulkens PM, Van Bambeke F. Mesaros N, et al. Among authors: van bambeke f. J Antimicrob Chemother. 2007 Mar;59(3):378-86. doi: 10.1093/jac/dkl504. Epub 2007 Feb 8. J Antimicrob Chemother. 2007. PMID: 17289770

9

Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.

Avrain L, Garvey M, Mesaros N, Glupczynski Y, Mingeot-Leclercq MP, Piddock LJ, Tulkens PM, Vanhoof R, Van Bambeke F. Avrain L, et al. Among authors: van bambeke f. J Antimicrob Chemother. 2007 Nov;60(5):965-72. doi: 10.1093/jac/dkm292. Epub 2007 Aug 10. J Antimicrob Chemother. 2007. PMID: 17693451

10

Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Van Bambeke F, Reinert RR, Appelbaum PC, Tulkens PM, Peetermans WE. Van Bambeke F, et al. Drugs. 2007;67(16):2355-82. doi: 10.2165/00003495-200767160-00005. Drugs. 2007. PMID: 17983256 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page